longbridge

Generate Biomedicines

GENB
----

All Shareholders

Shareholder Type

  • VC/PE firms48.83%
  • Institutions30.65%
  • Public and others16.44%
  • Individuals & Insiders4.07%

Major Shareholders

Major Shareholders Latest
Shareholder
Flagship Pioneering, Inc
48.83%62.67M0.06%+0
FMR LLC
4.07%5.22M0.78%+1.00M
Capital Research and Management Company
3.28%4.22M0.16%+211.48K
Braidwell LP
2.56%3.28M0.24%-309.16K
Michael NallyCEO & Director
2.25%2.89M<0.01%+0
T. Rowe Price Group, Inc.
1.68%2.16M0.03%+46.99K
Norges Bank Investment Management
1.63%2.09M--+2.09M
Arch Venture Partners, L.P.
1.51%1.94M<0.01%+0
Banque Pictet & Cie SA
1.38%1.77M--+1.77M
HarbourVest Partners, LLC
1.34%1.72M<0.01%+0
BlackRock, Inc.
1.29%1.66M--+1.66M
Baker Bros. Advisors LP
1.11%1.42M<0.01%+0
JP Morgan Asset Management
1.06%1.37M1.12%-1.43M
Deep Track Capital, LP
1.04%1.33M--+1.33M
Vanguard Capital Management, LLC
1.02%1.31M0.90%+1.16M
ARK Investment Management LLC
1.00%1.28M0.61%+786.21K
Stéphane BancelIndependent Director
0.92%1.18M<0.01%+0
Harvard Management Company, Inc.
0.87%1.11M<0.01%+0
GPU Ventures
0.65%833.33K<0.01%+0
Davern Capital Partners, LP
0.64%824.68K0.18%+232.88K
© 2026 Longbridge｜Terms of ServicePrivacy Policy